We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Smart Watches Could Identify Parkinson’s Disease Years before Symptoms Appear

By HospiMedica International staff writers
Posted on 10 Jul 2023
Print article
Image: Smart watches using AI could accurately predict those who can go on to develop Parkinson’s (Photo courtesy of Freepik)
Image: Smart watches using AI could accurately predict those who can go on to develop Parkinson’s (Photo courtesy of Freepik)

Parkinson's disease impacts brain cells known as dopaminergic neurons, predominantly located in an area called the substantia nigra. This condition leads to motor symptoms such as tremors, stiffness or rigidity, and slowed movements. Unfortunately, by the time these classic symptoms of Parkinson's become apparent, facilitating clinical diagnosis, over half of the substantia nigra cells have already died. Consequently, there's an urgent need for cost-effective, reliable, and readily available methods to detect early changes, thereby permitting intervention before the disease inflicts extensive brain damage. Now, new research has revealed that smartwatches could potentially identify Parkinson's up to seven years prior to the onset of characteristic symptoms and clinical diagnosis.

A study led by scientists at Cardiff University (Wales, UK) analyzed data gathered by smartwatches over a week, focusing on the speed of participants' movements. The researchers examined data derived from 103,712 UK Biobank participants who wore medical-grade smartwatches for a week between 2013 and 2016. These devices continuously measured average acceleration, or movement speed, throughout the seven-day span. The team compared data from a subset of participants already diagnosed with Parkinson's disease to another group diagnosed up to seven years after the smartwatch data collection. They also compared these groups to age and sex-matched healthy individuals.

The researchers discovered that they could accurately predict, using artificial intelligence (AI), who would eventually develop Parkinson's disease. Not only could they differentiate these participants from the healthy controls, but they also demonstrated that the AI could identify individuals in the general population who would later develop Parkinson's. This method was found to be more precise than any other risk factor or recognized early disease sign in predicting Parkinson's development. The machine learning model was also capable of predicting the time to diagnosis. According to the researchers, this could serve as a novel screening tool for Parkinson's disease, facilitating detection at much earlier stages than current methods permit.

“Smartwatch data is easily accessible and low-cost. As of 2020, around 30 percent of the UK population wear smart watches. By using this type of data, we would potentially be able to identify individuals in the very early stages of Parkinson’s disease within the general population,” said study leader Dr. Cynthia Sandor, Emerging Leader at the UK Dementia Research Institute at Cardiff University.

“We have shown here that a single week of data captured can predict events up to seven years in the future. With these results we could develop a valuable screening tool to aid in the early detection of Parkinson’s. This has implications both for research, in improving recruitment into clinical trials, and in clinical practice, in allowing patients to access treatments at an earlier stage, in future when such treatments become available,” added Dr. Sandor

Related Links:
Cardiff University 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Transport Ventilator
TV80

Print article

Channels

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.